Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
CRNX holding history
Crinetics Pharmaceuticals, Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings
- Shares (Q2 2026)
- 75,000
- Value
- $2.81M
- % of portfolio
- 0.1%
- Quarters held
- 12
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 75,000 | $2.81M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 75,000 | $2.72M | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2025 | 75,000 | $3.49M | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2025 | 75,000 | $3.12M | 0.3% | −77,252−50.7% | Reduced | Holders |
| Q2 2025 | 152,252 | $4.38M | 0.6% | 00.0% | Unchanged | Holders |
| Q1 2025 | 152,252 | $5.11M | 0.8% | −307,748−66.9% | Reduced | Holders |
| Q4 2024 | 460,000 | $23.5M | 3.7% | +60,000+15.0% | Added | Holders |
| Q3 2024 | 400,000 | $20.4M | 3.2% | −115,000−22.3% | Reduced | Holders |
| Q2 2024 | 515,000 | $23.1M | 3.6% | +45,000+9.6% | Added | Holders |
| Q1 2024 | 470,000 | $22.0M | 3.6% | +22,905+5.1% | Added | Holders |
| Q4 2023 | 447,095 | $15.9M | 3.2% | −2,905−0.6% | Reduced | Holders |
| Q3 2023 | 450,000 | $13.4M | 4.4% | +450,000 | New | Holders |